hepatitis B immune globulin

Known as: hepatitis b immunoglobulin, Human hepatitis-B immunoglobulin, hepatitis B hyperimmune globulin 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1970-2017
0204019702017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
OBJECTIVES:The long-term outcomes of oral antiviral therapy without hepatitis B immune globulin (HBIG) in prevention of… (More)
  • table 1
  • figure 2
  • figure 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2011
Highly Cited
2011
BACKGROUND & AIMS In the Asia-Pacific region, perinatal transmission of the hepatitis B virus (HBV) is the primary cause of… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2009
Highly Cited
2009
This randomized, double-blind, placebo-controlled study evaluated whether lamivudine given during late pregnancy can reduce… (More)
  • figure 1
  • table 2
  • table 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Seventy-seven liver transplant candidates were enrolled in a multicenter study in which patients were treated with lamivudine… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Although antiviral prophylaxis with lamivudine monotherapy appears to reduce post-liver transplantation recurrence of hepatitis B… (More)
Is this relevant?
2000
2000
The prevention of recurrent hepatitis B virus (HBV) infection after orthotopic liver transplantation (OLT) with hepatitis B… (More)
Is this relevant?
1999
1999
Immunoprophylaxis using intravenous (IV) hepatitis B immune globulin (HBIG) decreases the recurrence of hepatitis B virus (HBV… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Patients undergoing liver transplantation for hepatitis B-related liver disease are prone to recurrence. The mainstay of… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Long-term hepatitis B immune globulin (HBIG) has been shown to reduce hepatitis B virus (HBV) reinfection in patients… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
1983
Highly Cited
1983
A randomised blind controlled trial of hepatitis B immune globulin (HBIG) plus hepatitis B vaccine for the prevention of the… (More)
Is this relevant?